Cargando…
NEONOD 2: Rationale and design of a multicenter non-inferiority trial to assess the effect of axillary surgery omission on the outcome of breast cancer patients presenting only micrometastasis in the sentinel lymph node after neoadjuvant chemotherapy
Sentinel lymph node biopsy alone, without complete axillary lymph node dissection, is the standard treatment of the axilla nodal chain in early-stage breast cancer patients presenting a negative sentinel lymph node. The updated results of the IBCSG 23-01 randomized trial recently provided evidence t...
Autores principales: | Tinterri, Corrado, Canavese, Giuseppe, Bruzzi, Paolo, Dozin, Beatrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909193/ https://www.ncbi.nlm.nih.gov/pubmed/31872159 http://dx.doi.org/10.1016/j.conctc.2019.100496 |
Ejemplares similares
-
Omission of axillary sentinel lymph node biopsy in early invasive breast cancer
por: Reimer, Toralf
Publicado: (2023) -
Breast metastasis of primary colon cancer with micrometastasis in the axillary sentinel node: A metastasis that metastasized?
por: Perin, Tiziana, et al.
Publicado: (2011) -
Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment
por: Tinterri, Corrado, et al.
Publicado: (2023) -
Can Axillary Lymph Node Dissection Be Safely Omitted for Early-Stage Breast Cancer Patients with Sentinel Lymph Node Micrometastasis?
por: Damle, Sameer, et al.
Publicado: (2009) -
The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro‐metastases
por: Houvenaeghel, Gilles, et al.
Publicado: (2022)